Pharmanutra S.p.A. (BIT: PHN)

Pharmanutra Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	112.24	100.2	82.72	68.11	56.45	53.62
Other Revenue	1.43	0.83	0.34	0.03	0.32	0.05
Revenue	113.67	101.03	83.06	68.14	56.77	53.67
Revenue Growth (YoY)	20.20%	21.64%	21.89%	20.04%	5.78%	14.67%
Cost of Revenue	68.61	52.09	41.14	35.99	30.25	30.9
Gross Profit	45.06	48.95	41.92	32.15	26.52	22.77
Selling, General & Admin	12.95	22.55	17.19	12.12	9.95	9.48
Other Operating Expenses	0.77	0.43	0.34	0.34	1.11	0.22
Operating Expenses	18.14	25.6	18.84	13.86	12.35	10.68
Operating Income	26.91	23.35	23.07	18.3	14.17	12.09
Interest Expense	-1.46	-0.8	-0.06	-0.02	-0.03	-0.04
Interest & Investment Income	0.1	0.32	0.13	0.15	0.09	0.07
Currency Exchange Gain (Loss)	0.05	0.08	-0.03	-	0	-0
Other Non Operating Income (Expenses)	1.45	0.84	0.34	0.4	0.66	0.11
EBT Excluding Unusual Items	27.05	23.79	23.45	18.83	14.88	12.22
Gain (Loss) on Sale of Assets	-0.01	-0.03	-0.03	-0.02	-0.07	-0.03
Legal Settlements	-0.5	-0.5	-	-	-	-
Other Unusual Items	-0.18	-	-	-	-1.51	-
Pretax Income	26.36	23.26	23.42	18.81	13.3	12.2
Income Tax Expense	10.09	10.43	8.37	5.04	-0.77	3.74
Earnings From Continuing Operations	16.27	12.83	15.05	13.77	14.07	8.45
Net Income to Company	-	12.83	15.05	13.77	14.07	8.45
Net Income	16.27	12.83	15.05	13.77	14.07	8.45
Preferred Dividends & Other Adjustments	-	-	-	-	0	-
Net Income to Common	16.27	12.83	15.05	13.77	14.07	8.45
Net Income Growth	36.27%	-14.73%	9.27%	-2.14%	66.45%	-1.20%
Shares Outstanding (Basic)	-	10	10	10	10	10
Shares Outstanding (Diluted)	-	10	10	10	10	10
Shares Change (YoY)	-	-0.05%	-0.09%	-	-	-
EPS (Basic)	-	1.33	1.56	1.42	1.45	0.87
EPS (Diluted)	-	1.33	1.56	1.42	1.45	0.87
EPS Growth	-	-14.69%	9.37%	-2.13%	66.44%	-1.20%
Free Cash Flow	19.42	-1.16	-8.69	15.43	10.12	7.12
Free Cash Flow Per Share	-	-0.12	-0.90	1.59	1.04	0.74
Dividend Per Share	0.850	0.850	0.800	0.710	0.670	0.460
Dividend Growth	6.25%	6.25%	12.68%	5.97%	45.65%	9.52%
Gross Margin	39.64%	48.45%	50.47%	47.18%	46.71%	42.43%
Operating Margin	23.68%	23.11%	27.78%	26.85%	24.95%	22.53%
Profit Margin	14.31%	12.70%	18.12%	20.21%	24.79%	15.75%
Free Cash Flow Margin	17.09%	-1.15%	-10.46%	22.64%	17.82%	13.27%
EBITDA	30.47	25.23	24.22	19.3	15.1	12.92
EBITDA Margin	26.80%	24.97%	29.16%	28.33%	26.60%	24.08%
D&A For EBITDA	3.55	1.87	1.15	1.01	0.93	0.83
EBIT	26.91	23.35	23.07	18.3	14.17	12.09
EBIT Margin	23.68%	23.11%	27.78%	26.85%	24.95%	22.53%
Effective Tax Rate	38.27%	44.83%	35.74%	26.78%	-	30.69%
Revenue as Reported	114.27	101.96	83.39	68.84	58.68	54.21

Source: S&P Capital IQ. Standard template. Financial Sources.